Jane T Kurtzman, Matthew Swallow, Joshua J Horns, Tarah Woodle, Benjamin McCormick, Jeremy Myers
{"title":"Risk of Hypertension after Renal Trauma: An Analysis of a Large Insurance Claims Database.","authors":"Jane T Kurtzman, Matthew Swallow, Joshua J Horns, Tarah Woodle, Benjamin McCormick, Jeremy Myers","doi":"10.1016/j.urology.2025.07.045","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the risk of new-onset hypertension (HTN) after renal trauma (rT) using a large insurance claims database.</p><p><strong>Methods: </strong>We conducted a retrospective analysis of Merative MarketScan records from 2011- 2017. Patients with rT were compared to controls with isolated bladder or urethral trauma. Patients were excluded if they had both trauma types, pre-existing hypertension, < 1 year of pre-trauma enrollment data, or age < 18 years old. Kaplan-Meier curves and multivariate Cox proportional hazards models assessed HTN risk between groups.</p><p><strong>Results: </strong>7,882 patients (4,703 rT) were included. In total, 35% of rT patients developed de-novo HTN compared to 21% of controls (p < 0.001). Multivariate analysis demonstrated that patients who suffered rT were nearly twice as likely to develop de-novo HTN (HR 1.8, p<0.001). Patients with renal trauma managed with either angioembolization or nephrectomy were at greatest risk of HTN (HR 3.4 and 2.4, respectively, p values < 0.005). HTN risk was also associated with older age, female sex, higher Charlson Comorbidity Index, longer stay, diabetes, obesity, hyperlipidemia, and alcohol use.</p><p><strong>Conclusions: </strong>Patients who suffer rT are at increased risk of developing de-novo HTN. Patients who undergo nephrectomy or angioembolization appear to be at the greatest risk compared to controls. Following renal trauma, patients should be counseled on the risk of new HTN and receive close monitoring of their blood pressure over time.</p>","PeriodicalId":23415,"journal":{"name":"Urology","volume":" ","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2025-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.urology.2025.07.045","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To evaluate the risk of new-onset hypertension (HTN) after renal trauma (rT) using a large insurance claims database.
Methods: We conducted a retrospective analysis of Merative MarketScan records from 2011- 2017. Patients with rT were compared to controls with isolated bladder or urethral trauma. Patients were excluded if they had both trauma types, pre-existing hypertension, < 1 year of pre-trauma enrollment data, or age < 18 years old. Kaplan-Meier curves and multivariate Cox proportional hazards models assessed HTN risk between groups.
Results: 7,882 patients (4,703 rT) were included. In total, 35% of rT patients developed de-novo HTN compared to 21% of controls (p < 0.001). Multivariate analysis demonstrated that patients who suffered rT were nearly twice as likely to develop de-novo HTN (HR 1.8, p<0.001). Patients with renal trauma managed with either angioembolization or nephrectomy were at greatest risk of HTN (HR 3.4 and 2.4, respectively, p values < 0.005). HTN risk was also associated with older age, female sex, higher Charlson Comorbidity Index, longer stay, diabetes, obesity, hyperlipidemia, and alcohol use.
Conclusions: Patients who suffer rT are at increased risk of developing de-novo HTN. Patients who undergo nephrectomy or angioembolization appear to be at the greatest risk compared to controls. Following renal trauma, patients should be counseled on the risk of new HTN and receive close monitoring of their blood pressure over time.
期刊介绍:
Urology is a monthly, peer–reviewed journal primarily for urologists, residents, interns, nephrologists, and other specialists interested in urology
The mission of Urology®, the "Gold Journal," is to provide practical, timely, and relevant clinical and basic science information to physicians and researchers practicing the art of urology worldwide. Urology® publishes original articles relating to adult and pediatric clinical urology as well as to clinical and basic science research. Topics in Urology® include pediatrics, surgical oncology, radiology, pathology, erectile dysfunction, infertility, incontinence, transplantation, endourology, andrology, female urology, reconstructive surgery, and medical oncology, as well as relevant basic science issues. Special features include rapid communication of important timely issues, surgeon''s workshops, interesting case reports, surgical techniques, clinical and basic science review articles, guest editorials, letters to the editor, book reviews, and historical articles in urology.